237 related articles for article (PubMed ID: 33110238)
21. Biallelic ETV6 rearrangements by recurrent translocations t(7;12)(p15;p13) and t(3;12)(q26.2;p13) in acute myeloid leukemia.
Yamamoto K; Yakushijin K; Funakoshi Y; Inui Y; Okamura A; Matsuoka H; Minami H
Leuk Res; 2011 Nov; 35(11):e212-4. PubMed ID: 21803420
[No Abstract] [Full Text] [Related]
22. A case of atypical myelodysplastic syndrome with micromegakaryocytes, normal platelet count, and t(3;12)(q21;p13) with inv(3)(q21q26).
Schnittger S; Schoch C; Streubel B; Hinrichs HF; Otremba B; Parwaresch R; Fonatsch C
Genes Chromosomes Cancer; 1997 Nov; 20(3):292-8. PubMed ID: 9365837
[TBL] [Abstract][Full Text] [Related]
23. Acute Myeloid Leukemia With t(v;5q33) Is Associated With Poor Overall Survival and Often Lacks Myelodysplastic Features.
Yabe M; Tang G; Garcia-Manero G; Loghavi S; Lu X; Miranda RN; Medeiros LJ; Kantarjian HM; Bueso-Ramos CE; Khoury JD
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S85-90. PubMed ID: 26297286
[TBL] [Abstract][Full Text] [Related]
24. t(11;16)(q23;p13)/KMT2A-CREBBP in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm?
Xie W; Tang G; Wang E; Kim Y; Cloe A; Shen Q; Zhou Y; Garcia-Manero G; Loghavi S; Hu AY; Wang S; Bueso-Ramos CE; Kantarjian HM; Medeiros LJ; Hu S
Ann Hematol; 2020 Mar; 99(3):487-500. PubMed ID: 32006151
[TBL] [Abstract][Full Text] [Related]
25. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
26. t(7;12)(q36;p13) and t(7;12)(q32;p13)--translocations involving ETV6 in children 18 months of age or younger with myeloid disorders.
Slater RM; von Drunen E; Kroes WG; Weghuis DO; van den Berg E; Smit EM; van der Does-van den Berg A; van Wering E; Hählen K; Carroll AJ; Raimondi SC; Beverloo HB
Leukemia; 2001 Jun; 15(6):915-20. PubMed ID: 11417477
[TBL] [Abstract][Full Text] [Related]
27. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
[TBL] [Abstract][Full Text] [Related]
28. Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.
Salem A; Loghavi S; Tang G; Huh YO; Jabbour EJ; Kantarjian H; Wang W; Hu S; Luthra R; Medeiros LJ; Khoury JD
Am J Hematol; 2017 Jun; 92(6):520-528. PubMed ID: 28253536
[TBL] [Abstract][Full Text] [Related]
29. Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count.
Chan GC; Wang WC; Raimondi SC; Behm FG; Krance RA; Chen G; Freiberg A; Ingram L; Butler D; Head DR
Leukemia; 1997 Feb; 11(2):206-11. PubMed ID: 9009082
[TBL] [Abstract][Full Text] [Related]
30. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E
Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
[TBL] [Abstract][Full Text] [Related]
31. Translocation (3;21) characterizes crises in myeloid stem cell disorders.
Chen Z; Morgan R; Baer MR; Ligorsky R; Sandberg AA
Cancer Genet Cytogenet; 1991 Dec; 57(2):153-9. PubMed ID: 1756492
[TBL] [Abstract][Full Text] [Related]
32. Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as "AML not otherwise specified" (AML-NOS) or "AML with myelodysplasia-related changes" (AML-MRC).
Miesner M; Haferlach C; Bacher U; Weiss T; Macijewski K; Kohlmann A; Klein HU; Dugas M; Kern W; Schnittger S; Haferlach T
Blood; 2010 Oct; 116(15):2742-51. PubMed ID: 20581309
[TBL] [Abstract][Full Text] [Related]
33. Jumping Translocations in Myeloid Malignancies Associated With Treatment Resistance and Poor Survival.
Sanford D; DiNardo CD; Tang G; Cortes JE; Verstovsek S; Jabbour E; Ravandi F; Kantarjian H; Garcia-Manero G
Clin Lymphoma Myeloma Leuk; 2015 Sep; 15(9):556-62. PubMed ID: 26141213
[TBL] [Abstract][Full Text] [Related]
34. Ecotropic virus integration site-1 gene preferentially expressed in post-myelodysplasia acute myeloid leukemia: possible association with GATA-1, GATA-2, and stem cell leukemia gene expression.
Ohyashiki JH; Ohyashiki K; Shimamoto T; Kawakubo K; Fujimura T; Nakazawa S; Toyama K
Blood; 1995 Jun; 85(12):3713-8. PubMed ID: 7780155
[TBL] [Abstract][Full Text] [Related]
35. Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms.
Sanada M; Uike N; Ohyashiki K; Ozawa K; Lili W; Hangaishi A; Kanda Y; Chiba S; Kurokawa M; Omine M; Mitani K; Ogawa S
Leukemia; 2007 May; 21(5):992-7. PubMed ID: 17315020
[TBL] [Abstract][Full Text] [Related]
36. Distinct pathologic feature of myeloid neoplasm with t(v;11p15); NUP98 rearrangement.
Lauw MIS; Qi Z; Eversmeyer L; Prakash S; Wen KW; Yu J; Monaghan SA; Aggarwal N; Wang L
Hum Pathol; 2022 May; 123():11-19. PubMed ID: 35167894
[TBL] [Abstract][Full Text] [Related]
37. A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG).
Jaju RJ; Haas OA; Neat M; Harbott J; Saha V; Boultwood J; Brown JM; Pirc-Danoewinata H; Krings BW; Müller U; Morris SW; Wainscoat JS; Kearney L
Blood; 1999 Jul; 94(2):773-80. PubMed ID: 10397745
[TBL] [Abstract][Full Text] [Related]
38. Translocation (12;17)(q13;q23) in de novo acute myeloid leukemia with trilineage myelodysplasia.
Wong KF; So CC; Yu PH
Cancer Genet Cytogenet; 1999 Oct; 114(2):159-61. PubMed ID: 10549276
[TBL] [Abstract][Full Text] [Related]
39. Trisomy 11 in myelodysplastic syndromes defines a unique group of disease with aggressive clinicopathologic features.
Wang SA; Jabbar K; Lu G; Chen SS; Galili N; Vega F; Jones D; Raza A; Kantarjian H; Garcia-Manero G; McDonnell TJ; Medeiros LJ
Leukemia; 2010 Apr; 24(4):740-7. PubMed ID: 20072149
[TBL] [Abstract][Full Text] [Related]
40. Azacitidine treatment for patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 3q abnormalities.
Wanquet A; Prebet T; Berthon C; Sebert M; Roux C; Kulasekararaj A; Micol JB; Esterni B; Itzykson R; Thepot S; Recher C; Delaunay J; Dreyfus F; Mufti G; Fenaux P; Vey N
Am J Hematol; 2015 Oct; 90(10):859-63. PubMed ID: 26113240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
